Last reviewed · How we verify
NCT05488574: Breathing
Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss
NA trial testing Deep breathing with Yoga positioning in Weight Loss in 80 participants. Status unknown.
23 November 2022
Quick facts
| Lead sponsor | Touro University Nevada |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 80 |
| Start date | 20 September 2022 |
| Primary completion | 23 November 2022 |
| Estimated completion | 23 November 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Deep breathing with Yoga positioning
Conditions studied
- Weight Loss — all drugs for Weight Loss →
- Metabolism — all drugs for Metabolism →
Sponsor
Touro University Nevada
Who can join
Adults 20 to 70, any sex, with Weight Loss or Metabolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to evaluate the physical and cognitive effects of a 15 min per day novel breathing and mindfulness moving-meditation program on metabolism, cognition, and emotion health. It is thought that the breathing and movement program will increase basal metabolism, facilitate fat loss, and decrease depressive behaviors. Anthropometric, blood chemistries, and cognitive measures of depression, sleep, and hunger will be measured over a two-month interventional program.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05488574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Weight Loss
Currently open trials in the same condition.
- NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
- NCT07223983 — Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) · Phase 1 · recruiting
- NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder · Phase 4 · recruiting
- NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance · NA · recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other Touro University Nevada trials
Trials by the same sponsor.
- NCT05790772 — Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers · NA · completed
- NCT05515926 — Physiological Responses to Osteopathic Manipulative Techniques in Healthy Young Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05488574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Touro University Nevada
- Last refreshed: 24 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05488574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing